Related references
Note: Only part of the references are listed.HIV Infection, Inflammation, Immunosenescence, and Aging
Steven G. Deeks
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals
Jennifer E. Ho et al.
AIDS (2010)
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study
Frank J. Palella et al.
AIDS (2010)
The Effect of HAART on HIV RNA Trajectory Among Treatment-naive Men and Women A Segmental Bernoulli/Lognormal Random Effects Model With Left Censoring
Haitao Chu et al.
EPIDEMIOLOGY (2010)
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
Benoit Marin et al.
AIDS (2009)
Racial and Sex Disparities in Life Expectancy Losses among HIV-Infected Persons in the United States: Impact of Risk Behavior, Late Initiation, and Early Discontinuation of Antiretroviral Therapy
Elena Losina et al.
CLINICAL INFECTIOUS DISEASES (2009)
Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression
Lars Peters et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Trends in Mortality and Causes of Death Among Women With HIV in the United States: A 10-Year Study
Audrey L. French et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Intracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus
Stacy M. Horner et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
Maud Mavigner et al.
PLOS ONE (2009)
CD4+count and risk of non-AIDS diseases following initial treatment for HIV infection
Jason V. Baker et al.
AIDS (2008)
Changes in the risk of death after HIV seroconversion compared with mortality in the general population
Krishnan Bhaskaran et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Toll like receptors and viruses
Robert W. Finberg et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: A Nationwide Cohort Study
N Weis et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy
Patrick S. Sullivan et al.
AIDS (2006)
Immunologic response to antiretroviral therapy in hepatitis C virus - Coinfected adults in a population-based HIV/AIDS treatment program
P Braitstein et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immunopathogenesis of hepatitis C virus infection: Multifaceted strategies subverting innate and adaptive immunity
Tatsuya Kanto et al.
INTERNAL MEDICINE (2006)
Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: An application using a Bayesian random change-point model
HT Chu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
JK Rockstroh et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-Naive HIV-Infected individuals
G Antonucci et al.
CLINICAL INFECTIOUS DISEASES (2005)
Negative regulation of Toll-like receptor-mediated immune responses
FY Liew et al.
NATURE REVIEWS IMMUNOLOGY (2005)
TLR3 in antiviral immunity: key player or bystander?
M Schroder et al.
TRENDS IN IMMUNOLOGY (2005)
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
AC Karlsson et al.
AIDS (2004)
Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy
K Anastos et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Viral blip dynamics during highly active antiretroviral therapy
M Di Mascio et al.
JOURNAL OF VIROLOGY (2003)
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years
DV Havlir et al.
JOURNAL OF VIROLOGY (2003)
The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy
MB Klein et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Interleukin-10 therapy - Review of a new approach
K Asadullah et al.
PHARMACOLOGICAL REVIEWS (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Hepatitis C and progression of HIV disease
MS Sulkowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub et al.
LANCET (2000)
Share Paper
